The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia
Open accessAbstract
Eleven studies now report significant associations between schizophrenia and certain haplotypes of singlenucleotide polymorphisms in the gene encoding dysbindin-1 at 6p22.3.Dysbindin-1 is best known as dystrobrevin-binding protein 1 (DTNBP1) and may thus be associated with the dystrophin glycoprotein complex found at certain postsynaptic sites in the brain.Contrary to expectations, however, we found that when compared to matched, nonpsychiatric controls, 73-93% of cases in two schizophrenia populations displayed presynaptic dysbindin-1 reductions averaging 18-42% (P = 0.027-0.0001)at hippocampal formation sites lacking neuronal dystrobrevin (i.e., β-dystrobrevin).The reductions, which were not observed in the anterior cingulate of the same schizophrenia cases, occurred specifically in terminal fields of intrinsic, glutamatergic afferents of the subiculum, the hippocampus proper, and especially the inner molecular layer of the dentate gyrus (DGiml).An inversely correlated increase in vesicular glutamate transporter-1 (VGluT-1) occurred in DGiml of the same schizophrenia cases.Those changes occurred without evidence of axon terminal loss or neuroleptic effects on dysbindin-1 or VGluT-1.Our findings indicate that presynaptic dysbindin-1 reductions independent of the dystrophin glycoprotein complex are frequent in schizophrenia and are related to glutamatergic alterations in intrinsic hippocampal formation connections.Such changes may contribute to the cognitive deficits common in schizophrenia.Nonstandard abbreviations used: cornu ammonis fields 1-3 of the hippocampus (CA1-3); dentate gyrus (DG); DG granule cell layer (DGg); DG hilus (DGh); DG inner molecular layer (DGiml); diaminobenzidine (DAB); hippocampal formation (i.e., CA1-3 + DG + subiculum) (HF); neuronal nucleus antibody (NeuN); postmortem interval (PMI); single-nucleotide polymorphism (SNP); vesicular glutamate transporter-1 (VGluT-1).Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paxinos, G. (1985) · Cited by 3,715
Paxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Self-citationGenome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
Requirement for Hippocampal CA3 NMDA Receptors in Associative Memory Recall
Nakazawa, K., Quirk, M. C., Chitwood, R. A., Watanabe, M., Yeckel, M. F., Sun, L. D., Kato, A., Carr, C. A., Johnston, D., Wilson, M. A., et al. (2002) · Science · doi:10.1126/science.1071795 · Cited by 1,099
Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat
Ishizuka, N., Weber, J., & Amaral, D. G. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902950407 · Cited by 886
Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 856
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Relating Hippocampal Circuitry to Function
Lisman, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)81085-5 · Cited by 607
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Anatomical organization of the parahippocampal-hippocampal network
WITTER, M. P., WOUTERLOOD, F. G., NABER, P. A., & VAN HAEFTEN, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06716.x · Cited by 567 · cited 1×
“Figure 10C diagrams the primary course of the information flow, much of which derives from entorhinal cortex input that conveys information from many cerebrocortical areas (48, 49, 65).”
BackgroundThe Stanley Foundation brain collection and Neuropathology Consortium
Torrey, E. F., Webster, M., Knable, M., Johnston, N., & Yolken, R. H. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00192-9 · Cited by 533
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513 · cited 1×
“Such alterations are among the few neurobiological hallmarks of schizophrenia (31, 32).”
BackgroundLi, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O'Brien, E. P., Tinsley, C. L., Blake, D. J., Spritz, R. A., Copeland, N. G., et al. (2003) · Nature Genetics · doi:10.1038/ng1229 · Cited by 433
Self-citationBringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain
Kaneko, T., Fujiyama, F., & Hioki, H. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10129 · Cited by 394
Mirnics, K., Middleton, F. A., Lewis, D. A., & Levitt, P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01862-2 · Cited by 392
Vizi, E. S., & Kiss, J. P. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1998)8:6<566::aid-hipo2>3.0.co;2-w · Cited by 361
Schwab, S. G., Knapp, M., Mondabon, S., Hallmayer, J., Borrmann-Hassenbach, M., Albus, M., Lerer, B., Rietschel, M., Trixler, M., Maier, W., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345463 · Cited by 354
Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature
Goldner, E. M., Hsu, L., Waraich, P., & Somers, J. M. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700904 · Cited by 339
Antigen retrieval techniques in immunohistochemistry: comparison of different methods
Pileri, S. A., Roncador, G., Ceccarelli, C., Piccioli, M., Briskomatis, A., Sabattini, E., Ascani, S., Santini, D., Piccaluga, P. P., Leone, O., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199709)183:1<116::aid-path1087>3.0.co;2-2 · Cited by 338
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 321
Benson, M. A., Newey, S. E., Martin-Rendon, E., Hawkes, R., & Blake, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010418200 · Cited by 304
Self-citationAltered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice)
Knuesel, I., Mastrocola, M., Zuellig, R. A., Bornhauser, B., Schaub, M. C., & Fritschy, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00887.x · Cited by 241
Cis-acting variation in the expression of a high proportion of genes in human brain
Bray, N. J., Buckland, P. R., Owen, M. J., & O'Donovan, M. C. (2003) · Human Genetics · doi:10.1007/s00439-003-0956-y · Cited by 232
Different Dystrophin-like Complexes Are Expressed in Neurons and Glia
Blake, D. J., Hawkes, R., Benson, M. A., & Beesley, P. W. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.645 · Cited by 232
Self-citationAsymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia
Harrison, P. J., & Eastwood, S. L. (2001) · Hippocampus · doi:10.1002/hipo.1067 · Cited by 223
Eastwood, S. L., McDonald, B., Burnet, P. W. J., Beckwith, J. P., Kerwin, R. W., & Harrison, P. J. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00247-c · Cited by 207
The DTNBP1 (Dysbindin) Gene Contributes to Schizophrenia, Depending on Family History of the Disease
Van Den Bogaert, A., Schumacher, J., Schulze, T. G., Otte, A. C., Ohlraun, S., Kovalenko, S., Becker, T., Freudenberg, J., Jönsson, E. G., Mattila-Evenden, M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379928 · Cited by 193
Williams, N. M., Preece, A., Morris, D. W., Spurlock, G., Bray, N. J., Stephens, M., Norton, N., Williams, H., Clement, M., Dwyer, S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.336 · Cited by 190
Interneurons in the Hippocampal Dentate Gyrus: an In Vivo intracellular Study
Sik, A., Penttonen, M., & Buzsáki, G. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01634.x · Cited by 189
3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion.
Maddox, P. H., & Jenkins, D. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.10.1256 · Cited by 187
β-dystrobrevin, a member of the dystrophin-related protein family
Blake, D. J., Nawrotzki, R., Loh, N. Y., Górecki, D. C., & Davies, K. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.241 · Cited by 177
Self-citationRecent advances in the genetics of schizophrenia
O’Donovan, M. C., Williams, N. M., & Owen, M. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg302 · Cited by 174
Scharfman, H. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01660.1991 · Cited by 170
Linkage and associated studies of schizophrenia
Riley, B. P., & McGuffin, P. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(200021)97:1<23::aid-ajmg5>3.0.co;2-k · Cited by 169
Brünig, I., Suter, A., Knuesel, I., Lüscher, B., & Fritschy, J.-M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04805.2002 · Cited by 169
Porter, R. H. P., Eastwood, S. L., & Harrison, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01404-7 · Cited by 158
Kirov, G., Ivanov, D. K., Williams, N. M., Preece, A. C., Nikolov, I., Milev, R., Koleva, S., Dimitrova, A., Toncheva, D. I., O’Donovan, M. C., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.025 · Cited by 156
Neurocognitive Deficits in Schizophrenia
Goldberg, T. E., David, A. S., & Gold, J. M. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch10 · Cited by 142
Family-based association study of DTNBP1 in 6p22.3 and schizophrenia
Tang, J., Zhou, J. P., Fan, J., Li, X. W., Shi, Y., Gu, N. F., Feng, G. Y., Xing, Y. L., Shi, J., & He, L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001287 · Cited by 139
van den Oord, E. J. C. G., Sullivan, P. F., Jiang, Y., Walsh, D., O’Neill, F. A., Kendler, K. S., & Riley, B. P. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001263 · Cited by 133
Kapur, S., Zipursky, R. B., Roy, P., Jones, C., Remington, G. J., Reed, K. L., & Houle, S. (1997) · Psychopharmacology · doi:10.1007/s002130050277 · Cited by 126
Postmortem Studies of the Hippocampal Formation in Schizophrenia
Dwork, A. J. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.385 · Cited by 117
Estimated Neuronal Populations and Volumes of the Hippocampus and Its Subfields in Schizophrenia
Walker, M. A., Highley, J. R., Esiri, M. M., McDonald, B., Roberts, H. C., Evans, S. P., & Crow, T. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.821 · Cited by 111
Dystrophin in the Nervous System
Lidov, H. G. W. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00783.x · Cited by 110
Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients
Arnold, S. E., Gur, R. E., Shapiro, R. M., Fisher, K. R., Moberg, P. J., Gibney, M., Gur, R. C., Blackwell, P., & Trojanowski, J. Q. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.731 · Cited by 109
Self-citationPostembryonic Neuronal Plasticity and its Hormonal Control During Insect Metamorphosis
Weeks, J. C., & Levine, R. B. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.001151 · Cited by 102
Wenzel, H. J., Buckmaster, P. S., Anderson, N. L., Wenzel, M., & Schwartzkroin, P. A. (1997) · Hippocampus · doi:10.1002/(sici)1098-1063(1997)7:5<559::aid-hipo11>3.0.co;2-# · Cited by 100
L INKAGE A NALYSIS IN P SYCHIATRIC D ISORDERS : The Emerging Picture
Sklar, P. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103141 · Cited by 100
The genetics of schizophrenia: glutamate not dopamine?
Collier, D. A., & Li, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.105 · Cited by 99
Morris, D. W., McGhee, K. A., Schwaiger, S., Scully, P. J., Quinn, J., Meagher, D. J., Waddington, J. L., Gill, M., & Corvin, A. P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00527-3 · Cited by 94
Jackson, M. B., & Scharfman, H. E. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.1.601 · Cited by 94
Small, S. A. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.2.183 · Cited by 93
The discovery of susceptibility genes for mental disorders
Cloninger, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222532599 · Cited by 85
The parahippocampal region : implications for neurological and psychiatric diseases
Scharfman, H. E., Witter, M. P., & Schwarcz, R. M. (2000) · Medical Entomology and Zoology · Cited by 72
Schizophrenia: Neural Mechanisms for Novel Therapies
Sawa, A., & Snyder, S. H. (2003) · Molecular Medicine · doi:10.1007/bf03402101 · Cited by 61
Surgically Implantable Long-term Antipsychotic Delivery Systems for the Treatment of Schizophrenia
Siegel, S. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00426-2 · Cited by 53
Self-citationHetherington, P. A., Austin, K. B., & Shapiro, M. L. (1994) · Hippocampus · doi:10.1002/hipo.450040405 · Cited by 47
Genetics of Schizophrenia and Affective Disorders
Maier, W., Zobel, A. W., & Rietschel, M. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45130 · Cited by 46
Petrozzino, J. J., & Connor, J. A. (1994) · Hippocampus · doi:10.1002/hipo.450040504 · Cited by 45
Hippocampal dysfunction in schizophrenia
Schmajuk, N. A. (2001) · Hippocampus · doi:10.1002/hipo.1074 · Cited by 44
Huard, J., Côté, P., Parent, A., Bouchard, J.-P., & Tremblay, J. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90890-j · Cited by 33
The Postmortem Brain in Psychiatric Research
Agam, G., Everall, I., & Belmaker, R. (2002) · Neurobiological Foundation of Aberrant Behaviors · doi:10.1007/978-1-4757-3631-1 · Cited by 30
Behavioral neuroscience: challenges for the era of molecular biology
Lederhendler, I. I., & Schulkin, J. A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01636-2 · Cited by 30
Teclemariam‐Mesbah, R., Wortel, J., Romijn, H. J., & Buijs, R. M. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500414 · Cited by 29
Dawirs, R. R., Teuchert‐Noodt, G., Hildebrandt, K., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070066 · Cited by 22
Bhaduri, A., Krishnaswamy, L., Ullal, G. R., Panicker, M. M., & Sowdhamini, R. (2003) · Journal of Molecular Modeling · doi:10.1007/s00894-002-0102-0 · Cited by 18
Research works printed but not linked: 6
- Bakker, 2003, Am. J. Med. Genet., 122B, 19
- Shi, 2003, Am. J. Med. Genet., 122B, 102
- Yamada, 2003, Am. J. Med. Genet., 122B, 131
- Maier, 2003, Pharmacopsychiatry., 36(Suppl. 3), 5195
- Straub, 2004, Biol. Psychiatry., 55(Suppl. 1), 116S
- Scharfman, 2000, Ann. N. Y. Acad. Sci., 911, ix, 10.1111/j.1749-6632.2000.tb06715.x · doi:10.1111/j.1749-6632.2000.tb06715.x
Cited by
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Self-citationInterneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
“The expression of dysbindin is reduced in prefrontal cortex and hippocampus in schizophrenia [147].”
BackgroundGlutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
“The expression of dysbindin is reduced in prefrontal cortex and hippocampus in schizophrenia (Talbot et al., 2004; Weickert et al., 2004).”
Background
Metadata
- Authors
- Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C.-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., Blake, D. J., & Arnold, S. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-05-01
- Volume
- 113
- Issue
- 9
- Pages
- 1353-1363
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2156420407
- Cited by
- 455
- References
- 70
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.